[1]
|
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS LONG AND SHORT), AND VARIANT ALA-130.
TISSUE=Brain;
DOI=10.1093/hmg/6.2.259; PubMed=9063746 [NCBI, ExPASy, EBI, Israel, Japan]
Pizzuti A.,
Novelli G.,
Ratti A.,
Amati F.,
Mari A.,
Calabrese G.,
Nicolis S.,
Silani V.,
Marino B.,
Scarlato G.,
Ottolenghi S.,
Dallapiccola B.;
"UFD1L, a developmentally expressed ubiquitination gene, is deleted in CATCH 22 syndrome.";
Hum. Mol. Genet. 6:259-265(1997).
|
[2]
|
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SHORT).
TISSUE=Heart;
Gong L.,
Yeh E.T.H.;
"Characterization of human UFD1, a ubiquitin fusion-degradation protein.";
Submitted (APR-1999) to the EMBL/GenBank/DDBJ databases.
|
[3]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM SHORT).
DOI=10.1186/gb-2004-5-10-r84; PubMed=15461802 [NCBI, ExPASy, EBI, Israel, Japan]
Collins J.E.,
Wright C.L.,
Edwards C.A.,
Davis M.P.,
Grinham J.A.,
Cole C.G.,
Goward M.E.,
Aguado B.,
Mallya M.,
Mokrab Y.,
Huckle E.J.,
Beare D.M.,
Dunham I.;
"A genome annotation-driven approach to cloning the human ORFeome.";
Genome Biol. 5:RESEARCH84.1-RESEARCH84.11(2004).
|
[4]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM SHORT).
TISSUE=Brain, and Skin;
DOI=10.1101/gr.2596504; PubMed=15489334 [NCBI, ExPASy, EBI, Israel, Japan] The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
|
[5]
|
INTERACTION WITH NPLOC4.
DOI=10.1016/S0378-1119(01)00649-7; PubMed=11574150 [NCBI, ExPASy, EBI, Israel, Japan]
Botta A.,
Tandoi C.,
Fini G.,
Calabrese G.,
Dallapiccola B.,
Novelli G.;
"Cloning and characterization of the gene encoding human NPL4, a protein interacting with the ubiquitin fusion-degradation protein (UFD1L).";
Gene 275:39-46(2001).
|
[6]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-247, AND MASS SPECTROMETRY.
TISSUE=Epithelium;
DOI=10.1021/pr070152u; PubMed=17924679 [NCBI, ExPASy, EBI, Israel, Japan]
Yu L.-R.,
Zhu Z.,
Chan K.C.,
Issaq H.J.,
Dimitrov D.S.,
Veenstra T.D.;
"Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.";
J. Proteome Res. 6:4150-4162(2007).
|
[7]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-299, AND MASS SPECTROMETRY.
DOI=10.1073/pnas.0611217104; PubMed=17287340 [NCBI, ExPASy, EBI, Israel, Japan]
Molina H.,
Horn D.M.,
Tang N.,
Mathivanan S.,
Pandey A.;
"Global proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry.";
Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
|
[8]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-245; SER-247 AND SER-299, AND MASS SPECTROMETRY.
DOI=10.1073/pnas.0805139105; PubMed=18669648 [NCBI, ExPASy, EBI, Israel, Japan]
Dephoure N.,
Zhou C.,
Villen J.,
Beausoleil S.A.,
Bakalarski C.E.,
Elledge S.J.,
Gygi S.P.;
"A quantitative atlas of mitotic phosphorylation.";
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
|
[9]
|
IDENTIFICATION [LARGE SCALE ANALYSIS], AND MASS SPECTROMETRY.
Colinge J.,
Superti-Furga G.,
Bennett K.L.;
Submitted (OCT-2008) to UniProtKB.
|
[10]
|
STRUCTURE BY NMR OF 11-193.
RIKEN structural genomics initiative (RSGI);
"Solution structure of human ubiquitin fusion degradation protein 1 homolog UFD1.";
Submitted (APR-2008) to the PDB data bank.
|
|